158 related articles for article (PubMed ID: 34414112)
41. Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy.
Yang S; Zhao W; Tan S; Zhang Y; Wei C; Chen T; Shen J
Transl Androl Urol; 2020 Jun; 9(3):1252-1261. PubMed ID: 32676408
[TBL] [Abstract][Full Text] [Related]
42. Combined Analysis of Biparametric MRI and Prostate-Specific Antigen Density: Role in the Prebiopsy Diagnosis of Gleason Score 7 or Greater Prostate Cancer.
Lee SJ; Oh YT; Jung DC; Cho NH; Choi YD; Park SY
AJR Am J Roentgenol; 2018 Sep; 211(3):W166-W172. PubMed ID: 30016148
[TBL] [Abstract][Full Text] [Related]
43. [Development of a Chinese nomogram based on muti-parametric magnetic resonance for predicting the probability of prostate cancer in patients after initial negative biopsy].
Huang C; Ji GJ; Song G; Wang H; Chen YK; Zhou LQ
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(2):132-135. PubMed ID: 29343039
[No Abstract] [Full Text] [Related]
44. MRI-Based Nomogram of Prostate Maximum Sectional Area and Its Zone Area for Prediction of Prostate Cancer.
Jiang S; Huang Z; Liu B; Chen Z; Xu Y; Zheng W; Wen Y; Li M
Front Oncol; 2021; 11():708730. PubMed ID: 34568034
[TBL] [Abstract][Full Text] [Related]
45. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
[TBL] [Abstract][Full Text] [Related]
46. Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China.
Na R; Ye D; Qi J; Liu F; Helfand BT; Brendler CB; Conran CA; Packiam V; Gong J; Wu Y; Zheng SL; Mo Z; Ding Q; Sun Y; Xu J
Prostate; 2017 Aug; 77(11):1221-1229. PubMed ID: 28664580
[TBL] [Abstract][Full Text] [Related]
47. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
[TBL] [Abstract][Full Text] [Related]
48. Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with "gray zone" PSA levels.
Wei CG; Chen T; Zhang YY; Pan P; Dai GC; Yu HC; Yang S; Jiang Z; Tu J; Lu ZH; Shen JK; Zhao WL
Eur J Radiol; 2020 Jun; 127():108977. PubMed ID: 32330776
[TBL] [Abstract][Full Text] [Related]
49. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP
BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037
[TBL] [Abstract][Full Text] [Related]
50. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
[TBL] [Abstract][Full Text] [Related]
51. Are prostate biopsies necessary for all patients 75years and older?
Chen Y; Fan Y; Yang Y; Jin J; Zhou L; He Z; Zhao Z; He Q; Wang X; Yu W; Wu S
J Geriatr Oncol; 2018 Mar; 9(2):124-129. PubMed ID: 28939384
[TBL] [Abstract][Full Text] [Related]
52. External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients.
Beauval JB; Cabarrou B; Gandaglia G; Patard PM; Ouzzane A; de la Taille A; Soulié M; Briganti A; Ploussard G; Rozet F; Roumiguié M
Prostate; 2017 Jun; 77(8):928-933. PubMed ID: 28370267
[TBL] [Abstract][Full Text] [Related]
53. Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone.
Guo ZF; Yang F; Lu XW; Wu JW; He C; Han CH
J Int Med Res; 2021 Jul; 49(7):3000605211019879. PubMed ID: 34308690
[TBL] [Abstract][Full Text] [Related]
54. Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.
Apfelbeck M; Pfitzinger P; Bischoff R; Rath L; Buchner A; Mumm JN; Schlenker B; Stief CG; Chaloupka M; Clevert DA
Clin Hemorheol Microcirc; 2020; 76(4):503-511. PubMed ID: 33337358
[TBL] [Abstract][Full Text] [Related]
55. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
Yim JH; Kim CK; Kim JH
J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
[TBL] [Abstract][Full Text] [Related]
56. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
[TBL] [Abstract][Full Text] [Related]
57. Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer.
Xu N; Ke ZB; Chen YH; Wu YP; Chen SH; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY
Front Oncol; 2020; 10():1547. PubMed ID: 32923401
[TBL] [Abstract][Full Text] [Related]
58. Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer.
Stevens E; Truong M; Bullen JA; Ward RD; Purysko AS; Klein EA
Urol Oncol; 2020 Nov; 38(11):846.e9-846.e16. PubMed ID: 32576527
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients.
Harraz AM; Atia N; Ismail A; Shady A; Farg H; Gabr H; Fouda M; Abol-Enein H; Abdel-Aziz AF
Int Urol Nephrol; 2020 Aug; 52(8):1483-1490. PubMed ID: 32166568
[TBL] [Abstract][Full Text] [Related]
60. Predictive model containing PI-RADS v2 score for postoperative seminal vesicle invasion among prostate cancer patients.
Wang H; Ruan M; Wang H; Li X; Hu X; Liu H; Zhou B; Song G
Transl Androl Urol; 2021 Feb; 10(2):584-593. PubMed ID: 33718061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
